Page last updated: 2024-10-24

T-helper 17 cell chemotaxis

Definition

Target type: biologicalprocess

The directed movement of a T-helper 17 cell in response to an external stimulus. [CL:0000899, GOC:BHF]

T-helper 17 (Th17) cell chemotaxis is a complex process that involves the directed migration of Th17 cells towards a chemical gradient. This process is crucial for the immune response to pathogens, particularly in the context of mucosal immunity.

Here's a detailed description of the process:

**1. Initiation of Chemotaxis:**

* **Pathogen Recognition:** Th17 cells express various receptors, including Toll-like receptors (TLRs) and cytokine receptors, that recognize pathogen-associated molecular patterns (PAMPs) from bacteria, fungi, and other pathogens.
* **Cytokine Production:** Upon PAMP recognition, Th17 cells produce pro-inflammatory cytokines like interleukin-17 (IL-17), IL-22, and TNF-α. These cytokines play a critical role in initiating the inflammatory response and recruiting other immune cells to the site of infection.
* **Chemokine Release:** Pathogens and host cells at the infection site release chemokines, such as CCL20, CCL2, and CXCL8. These chemokines act as chemoattractants for Th17 cells.

**2. Chemokine Sensing and Signaling:**

* **Chemokine Receptor Binding:** Th17 cells express chemokine receptors, including CCR6, CCR2, and CXCR1, which bind to specific chemokines. This binding activates intracellular signaling pathways.
* **Signal Transduction:** Chemokine receptor activation triggers a cascade of signaling events involving G proteins, phospholipase C, and calcium release. These events lead to changes in cell polarization and cytoskeletal rearrangements.

**3. Cell Polarization and Migration:**

* **Polarization:** The signaling cascade directs the assembly of the cell's cytoskeleton, leading to polarization of the cell. One end of the cell, the leading edge, extends towards the chemokine gradient.
* **Motility:** The polarized cell utilizes actin polymerization and myosin motor proteins to generate force, allowing it to move towards the chemokine source.
* **Chemotaxis:** This directed movement of Th17 cells along the chemokine gradient is known as chemotaxis.

**4. Th17 Cell Accumulation and Function:**

* **Immune Response:** Th17 cells migrate to the site of infection, where they release pro-inflammatory cytokines and recruit other immune cells, such as neutrophils and macrophages. This inflammatory response helps to clear the pathogen.
* **Tissue Repair:** After infection, Th17 cells contribute to tissue repair and restoration of homeostasis.

**5. Regulation of Chemotaxis:**

* **Immune Tolerance:** Mechanisms exist to regulate Th17 cell chemotaxis and prevent excessive inflammation. These mechanisms involve negative feedback loops, regulatory T cells, and other immune mediators.

In summary, Th17 cell chemotaxis is a tightly regulated process that involves pathogen recognition, chemokine signaling, cell polarization, and directed migration. This process is essential for the immune response against pathogens, particularly in mucosal tissues.'
"

Proteins (1)

ProteinDefinitionTaxonomy
C-C chemokine receptor type 2A C-C chemokine receptor type 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P41597]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
amiodaroneamiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
1-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound
cardiovascular drug
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
fasudilfasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

fasudil: intracellular calcium antagonist; structure in first source
isoquinolines;
N-sulfonyldiazepane
antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
nifedipineNifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.C-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
dibenzothiazyl disulfidedibenzothiazol-2-yl disulfide : An organic disulfide resulting from the formal oxidative coupling of the thiol groups of two molecules of 1,3-benzothiazole-2-thiol. It is used as an accelerator in the rubber industry.

dibenzothiazyl disulfide: vulcanizing accelerant
benzothiazoles;
organic disulfide
allergen
1-naphthylisothiocyanate1-Naphthylisothiocyanate: A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.isothiocyanateinsecticide
plerixaforplerixafor : An azamacrocycle consisting of two cyclam rings connected by a 1,4-phenylenebis(methylene) linker. It is a CXCR4 chemokine receptor antagonist and a hematopoietic stem cell mobilizer. It is used in combination with grulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the perpheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.

plerixafor: a bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2
azacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
fasudil hydrochloridefasudil hydrochloride : A hydrochloride obtained by reaction of fasudil with one equivalent of hydrochloric acid.hydrochlorideantihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
neuroprotective agent;
nootropic agent;
vasodilator agent
tak 779
bay 11-7085BAY11-7085 : A sulfone that is benzene substituted by [(E)-2-cyanoethenyl]sulfonyl and tert-butyl groups at position 1 and 4, respectively. It is an irreversible inhibitor of IkappaB-alpha phosphorylation in cells (IC50 = 10 muM) and prevents the activation of NF-kappaB.benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
ucb 35625UCB 35625: J-113863 is the (trans)-isomer; structure in first source
rs 504393RS 504393: structure in first source1,3-oxazoles
incb3344INCB3344: potent and selective small molecule CCR2 chemokine receptor antagonist
amd 070mavorixafor: a derivative of AMD3100; a CXCR4 blockeraminoquinoline
cenicriviroccenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).

cenicriviroc: an inhibitor of HIV-1
aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
incb 3284INCB 3284: a CCR2 receptor antagonist
azd8309AZD8309: CXCR2 inhibitor
n-(carbamoylmethyl)-3-trifluoromethyl benzamido-4-chlorobenzyl 3-aminopyrrolidine